Search research articles
Contact Us
Filters
Showing results (41-50 of 130) with videos related to
Page
of 13
Sort By:
Leukemia & Lymphoma
|
September 18, 2013
Interpreting MYC and BCL2 in diffuse large B-cell lymphoma
Catherine Lai, Cliona Grant, Kieron Dunleavy
Expert Review of Hematology
|
May 12, 2016
Double hit lymphoma: from biology to therapeutic implications
Mauricio Burotto, Alejandro Berkovits, Kieron Dunleavy
Cancer Treatment Reviews
|
March 18, 2018
Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma
Kieron Dunleavy, Tabea Erdmann, Georg Lenz
Blood
|
May 13, 2022
CAR T-cell therapy in highly aggressive B-cell lymphoma: emerging biological and clinical insights
Alaa Ali, Andre Goy, Kieron Dunleavy
Current Hematologic Malignancy Reports
|
July 21, 2012
Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes
Kieron Dunleavy, Mark Roschewski, Wyndham H Wilson
Journal of the National Cancer Institute
|
August 19, 2009
Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials
Ola Landgren, Kieron Dunleavy, Wyndham H Wilson
Therapeutic Advances in Hematology
|
April 24, 2013
Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma
Kieron Dunleavy, Cliona Grant, Wyndham H Wilson
Current Treatment Options in Oncology
|
June 7, 2021
Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma
Coen J Lap, Samah Nassereddine, Kieron Dunleavy
Current Opinion in Hematology
|
November 25, 2010
Neutropenia associated with rituximab therapy
Cliona Grant, Wyndham H Wilson, Kieron Dunleavy
Seminars in Hematology
|
March 31, 2010
Rituximab-associated neutropenia
Kieron Dunleavy, Kevin Tay, Wyndham H Wilson
Page
of 13
Search research articles
Search
Showing results (41-50 of 130) with videos related to
Sort By:
Page
of 13
Leukemia & Lymphoma
|
September 18, 2013
Interpreting MYC and BCL2 in diffuse large B-cell lymphoma
Catherine Lai, Cliona Grant, Kieron Dunleavy
Expert Review of Hematology
|
May 12, 2016
Double hit lymphoma: from biology to therapeutic implications
Mauricio Burotto, Alejandro Berkovits, Kieron Dunleavy
Cancer Treatment Reviews
|
March 18, 2018
Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma
Kieron Dunleavy, Tabea Erdmann, Georg Lenz
Blood
|
May 13, 2022
CAR T-cell therapy in highly aggressive B-cell lymphoma: emerging biological and clinical insights
Alaa Ali, Andre Goy, Kieron Dunleavy
Current Hematologic Malignancy Reports
|
July 21, 2012
Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes
Kieron Dunleavy, Mark Roschewski, Wyndham H Wilson
Journal of the National Cancer Institute
|
August 19, 2009
Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials
Ola Landgren, Kieron Dunleavy, Wyndham H Wilson
Therapeutic Advances in Hematology
|
April 24, 2013
Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma
Kieron Dunleavy, Cliona Grant, Wyndham H Wilson
Current Treatment Options in Oncology
|
June 7, 2021
Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma
Coen J Lap, Samah Nassereddine, Kieron Dunleavy
Current Opinion in Hematology
|
November 25, 2010
Neutropenia associated with rituximab therapy
Cliona Grant, Wyndham H Wilson, Kieron Dunleavy
Seminars in Hematology
|
March 31, 2010
Rituximab-associated neutropenia
Kieron Dunleavy, Kevin Tay, Wyndham H Wilson
Page
of 13